Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis

Rafiye Ciftciler Hakan GokerHaluk DemiroğluSalih AksuNilgün Sayınalpİbrahim Celallettin Haznedaroğlu Umit Yavuz MalkanYahya BüyükaşıkOsman Ilhami Özcebe

Published in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2019)

These findings lead us to suggest that MM patients with EM plasmacytoma at the time of diagnosis have poorer prognosis than patients without plasmacytoma, even if autologous stem cell transplantation is performed. The presence of EM involvement negatively affects survival outcomes.

Keyphrases

stem cell transplantation
end stage renal disease
ejection fraction
newly diagnosed
multiple myeloma
high dose
stem cells
patient reported outcomes
low dose
bone marrow
cell therapy